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Abstract
Background and Aims: Celiac disease (CD) is a chronic inflammatory disorder of the small intestine that is induced by
dietary wheat gluten proteins (gliadins) in genetically predisposed individuals. The overgrowth of potentially pathogenic
bacteria and infections has been suggested to contribute to CD pathogenesis. We aimed to study the effects of gliadin and
various intestinal bacterial strains on mucosal barrier integrity, gliadin translocation, and cytokine production.
Methodology/Principal Findings: Changes in gut mucosa were assessed in the intestinal loops of inbred Wistar-AVN rats
that were reared under germ-free conditions in the presence of various intestinal bacteria (enterobacteria and bifidobacteria
isolated from CD patients and healthy children, respectively) and CD-triggering agents (gliadin and IFN-c) by histology,
scanning electron microscopy, immunofluorescence, and a rat cytokine antibody array. Adhesion of the bacterial strains to
the IEC-6 rat cell line was evaluated in vitro. Gliadin fragments alone or together with the proinflammatory cytokine
interferon (IFN)-c significantly decreased the number of goblet cells in the small intestine; this effect was more pronounced
in the presence of Escherichia coli CBL2 and Shigella CBD8. Shigella CBD8 and IFN-c induced the highest mucin secretion and
greatest impairment in tight junctions and, consequently, translocation of gliadin fragments into the lamina propria. Shigella
CBD8 and E. coli CBL2 strongly adhered to IEC-6 epithelial cells. The number of goblet cells in small intestine increased by
the simultaneous incubation of Bifidobacterium bifidum IATA-ES2 with gliadin, IFN-c and enterobacteria. B. bifidum IATA-ES2
also enhanced the production of chemotactic factors and inhibitors of metalloproteinases, which can contribute to gut
mucosal protection.
Conclusions: Our results suggest that the composition of the intestinal microbiota affects the permeability of the intestinal
mucosa and, consequently, could be involved in the early stages of CD pathogenesis.
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Introduction
Mucosal surfaces of the gastrointestinal tract are continuously
exposed to environmental stimuli. The intestinal epithelium
constitutes the largest and most important barrier against external
environmental agents and has two critical functions: to prevent the
entry of harmful intraluminal microorganisms, antigens, and
toxins and to enable the selective translocation of dietary nutrients
and electrolytes into circulation.
One of the basic properties of gut-associated lymphoid tissue
(GALT) is oral tolerance (unresponsiveness) to harmless compo-
nents of microbiota and diet. Inappropriate immunological
reactions against food proteins, such as wheat components, can
lead to the breakdown of oral tolerance and the development of
intestinal immune disorders.
Celiac disease (CD) is a chronic immune-mediated enteropathy
of small intestine that is triggered by dietary wheat gluten, or
related rye and barley proteins in genetically susceptible indivi-
duals. More than 90% of patients carry HLA-DQ2/8 antigens.
The expression of these high-risk haplotypes in general population,
however, is 20% to 30%, only 3% to 5% of whom develop CD.
The involvement of genes for cytokines interleukin (IL)-21 and IL-
2 in CD pathogenesis has been reported recently [1–5]. The
ingestion of gluten is the key environmental cause linked to the
symptoms of CD, but also infections and the composition of the
intestinal microbiota might play a role in CD pathogenesis [6–10].
Gluten proteins are partially hydrolyzed by peptidases in the
gastrointestinal tract, so the gluten (gliadin)-derived peptides can
cross the epithelium and be converted by tissue transglutaminase
(TG) 2 into negatively charged peptides that have higher affinity
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presented by dendritic cells (DC) to CD4+ a/b T lymphocytes in
the jejunum. Activated gliadin-specific T cells up-regulate type 1
and 2 cytokines that activate other cell types. The substantial
increase in interferon (IFN)-c promotes a proinflammatory
environment and the activation of tissue enzymes, including
metalloproteinases and TG2, which are involved in CD
pathogenesis [11–16].
The outermost barrier of gut mucosa is formed by a single layer
of epithelial cells covered by thick, viscous and relatively
impermeable gel layer produced by goblet cells – mucus. This
mucus layer prevents direct contact between enteric pathogens
and epithelial cell surfaces, contains binding sites for resident
microbiota and maintains high concentrations of secretory IgA to
prevent pathogens from attaching and entering. Moreover, Paneth
cells producing various antimicrobial peptides or lysozymes
strengthen the first-line of defense against harmful agents [17–19].
The integrity and function of the intestinal epithelium depend
on a protein network that joins epithelial cells and consists of
transmembrane complexes: tight junctions (TJs), adherens junc-
tions, and desmosomes. TJs are present in most apical regions,
where they selectively regulate the paracellular passage of ions and
solutes and prevent the translocation of luminal antigens,
microorganisms, and their toxins. TJs are formed by integral
membrane proteins, primarily occludins and claudins. Claudins, a
family of at least 24 proteins, are expressed in specific tissues;
claudins 1-5 are expressed in the gut intestine. Occludins and
claudins contain a binding domain for a complex of proteins - the
zonula occludens (ZO-1, ZO-2, and ZO-3) - which is linked to the
actin cytoskeleton and signaling proteins. Increased permeability
of the epithelial barrier has been proposed to increase one’s
predisposition to intestinal inflammation and gastrointestinal
diseases, including CD. Gluten and its component, gliadin were
shown to alter the expression of TJ proteins and TJ-associated
ZO-1 and stimulate the production of zonulin [20–23].
Recently, the potential role of the microbiota in CD
pathogenesis has attracted attention. Indigenous commensal
microbiota is involved in the resistance to infection not only
through their direct interaction with pathogenic bacteria but also
through their influence on the host immune system. The
microbiota of CD patients showed different composition in feces
and duodenal biopsy specimens compared with healthy controls,
characterized by a preferential increase in the proportions of
Bacteroides and E. coli with virulence genes and by a reduction in
Bifidobacterium proportions [6–10,24–26].
In this study, we examined the effect of gliadin and the
proinflammatory cytokine IFN-c on the intestinal barrier in rat
intestinal loops in the presence of potentially pathogenic enteric
bacteria isolated from CD patients or a Bifidobacterium strain isolated
from healthy controls. The effects of these stimuli on mucosal
barrier (TJs), its architecture, the number of goblet cells, adhesion,
gliadin translocation, and cytokine secretion were compared.
Materials and Methods
Ethics Statement
All animal experiments were approved by the Laboratory
Animal Care and Use Committee of the Institute of Microbiology
v.v.i., Academy of Sciences of the Czech Republic, approval ID:
244/2009.
Gliadin fragments
Peptic fragments of gliadin (Sigma, St Louis, MO) were
prepared on a pepsin agarose gel (ICN, Biomedicals, Ohio) as
described [27,28]. Protein concentrations were measured by
bicinchoninic acid assay (BCA Protein assay, Pierce, Rockford,
IL). All reagents were tested by E-toxate test for lipopolysaccharide
(LPS) (Sigma, St. Louis, MO) and were below the limit of detection
(2 pg/ml).
Cell culture and stimulation
The rat normal small intestine epithelial cell line (IEC)-6 was
purchased from American Type Culture Collection (ATCC, CRL-
1592, Manassas, VA) and was grown in 45% Dulbecco’s Modified
Eagle Medium (DMEM) Glutamax and 45% RPMI 1640,
containing 10% inactivated (56uC for 30 min) fetal bovine serum
(FBS) (Gibco, Barcelona, Spain), 100 mg/ml streptomycin, 100 U/
ml penicillin, and 0.1 U/ml insulin (Sigma, St. Louis, MO) at
37uC and 5% CO2. Cells were stimulated with bacteria and
gliadin fragments (100 mg).
Bacterial strains and culture conditions
The following strains were used: Bifidobacterium bifidum IATA-
ES2 (CECT 7365), Shigella CBD8, and Escherichia coli CBL2. B.
bifidum IATA-ES2 was isolated from the feces of healthy babies
and identified as described previously [29,30]. E. coli CBL2 and
Shigella CBD8 were isolated from celiac patients and identified as
described by Sanchez et al. [26]. The Shigella strain was included to
exemplify the possible effects of an actual intestinal pathogen in
this disease context.
Bifidobacteria were grown routinely in de Man, Rogosa, and
Sharpe (MRS) broth (Scharlau Chemie SA, Barcelona, Spain) with
0.05% (w/v) cysteine and incubated at 37uC under anaerobic
conditions (AnaeroGen; Oxoid, Basingstoke, UK) for 22 h.
Enterobacteria were grown routinely in Violet Red Bile Dextrose
(VRBD) agar (Scharlau Chemie SA, Barcelona, Spain) at 37uC for
24 h under aerobic conditions.
Cells were harvested by centrifugation (60006g for 15 min) at
the stationary growth phase, washed 2 times with PBS, and
resuspended in PBS that contained 20% glycerol. Aliquots of these
suspensions were frozen in liquid nitrogen and stored at 280uC
until use. The number of live cells after storage was determined as
colony-forming units (CFUs) on MRS-C, Schadler, or VRBD agar
after 48 h incubation under optimal conditions. For all strains,
more than 90% cells were alive on thawing, and no significant
differences were observed during storage (4 months). One fresh
aliquot was thawed for each new experiment to avoid variabilities
in live bacterial cell numbers between experiments.
Bacterial adhesion assay
Rat epithelial cells (IEC-6 line) were grown in 24-well plates in
DMEM to confluence; the monolayers were washed twice with
PBS, and 250 ml of labeled bacterial cell suspension (at an
absorbance of 0.5 (10
6 CFU/ml) at 600 nm) was added to each
well.
Bacterial staining was performed with 10 mM 5-CFDA (5-
carboxyfluorescein diacetate) (Sigma, St. Louis, MO) as described
by Izquierdo et al. [29]. Briefly, labeled bacterial suspensions were
added to IEC-6 cultures at A600 0.50. The epithelial cells and
labeled bacteria were incubated together at 37uC for 1 h. IEC-6
cells were washed 2 times with PBS to remove nonadherent
bacteria, and adherent cells were lysed in 200 mL 1% SDS (Sigma,
St. Louis, MO) in 0.1 M NaOH at 37uC for 1 h [29].
Supernatants were collected in Costar black round-bottom
96-well plates (Corning Inc., Corning, NY, USA), and the
fluorescence was measured on a microplate fluorometer (Fluor-
oskan Ascent, Labsystem, Oy, Finland) with excitation and emis-
sion wavelengths of 485 nm and 538 nm, respectively. Adhesion
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from adherent bacteria, relative to the initial fluorescence of the
bacterial suspension per well.
Experimental animals
Wistar-AVN germ-free (GF) rats were reared in Trexler-type
plastic isolators under controlled sterile conditions. Granulated
gluten-free diet 02 (maize 57%, soya meal 30%, sunflower oil
1.5%, linseed oil 1.5%, salt, DL-lysine 0.5%, DL-methionine 1%,
mineral, and vitamin mixture) was sterilized regularly by
irradiation (59 kGy, Bioster, Czech Republic) [31,32].
Rat intestinal loops
The bacterial strains and gluten were tested in ligated ileal loops
of GF rats. Two-month-old GF inbred AVN rats (approximately
200 grams) were deprived of food for the 24 h before surgery (with
free access to water). The rats were premedicated intramuscularly
with 1 ml of a mixture of ketamine (10 mg/ml) and xylazine
(2 mg/ml).
The three ligated loops (each approximately 2 cm long) were
created with nylon ligatures in the jejunum and proximal ileum,
beginning approximately 3 cm from the ileocecal junction. Each
loop was followed by a short intervening segment (2 cm) that was
not inoculated [32]. Five hundred microliters of inoculum,
containing 10
6 CFU of bacteria alone or with gliadin (250 mg)
and/or IFN-c (250 U, AbD Serotec), was injected into the
intestinal loops. After inoculation, the jejunum was returned to the
abdomen, and the laparotomy incision was closed. After 8–9 h,
the rats were euthanized by severing of the carotid artery. Tissue
samples and contents of the loops were collected for further
analysis.
Immunohistology
Tissue from the loop was fixed immediately in 10% neutral
buffered formalin or Carnoy’s solution. The fixed tissues were cut
and processed using routine methods. Paraffin sections (5 mm)
were deparaffinized in xylene, rehydrated through an ethanol
gradient to water, and stained in periodic acid-Schiff (PAS) to
evaluate mucin-secreting goblet cells. The villi (10–15) in these
sections were examined by light microscopy to determine the
number of PAS-positive goblet cells per 100 enterocytes in the
intestinal tissue, expressed as the medians and quartiles from 5–10
independent measurements.
Gliadin was detected in the intestinal loops by immunolocal-
ization. Briefly, snap-frozen intestinal loop samples, embedded in
OCT (Tissue-tek, Sakura Fine Tek, Torrance, CA, USA), were
cryosectioned at 6 mm, air-dried, fixed for 5 min in acetone, and
stored at 220uC. The sections were washed and endogenous
peroxidase blocked by 1% H2O2. Then, the sections were
incubated with peroxidase-labeled monoclonal anti-gliadin anti-
bodies (Elisa Development Prague, Czech Republic) overnight at
4uC, washed, and incubated with Tyramide Signal Amplification -
TSA
TM Plus Fluorescence system (PerkinElmer, USA) for 30 min.
The samples were counterstained with Evans blue and Hoechst to
visualise tissue cells and nuclei. Afterwards the sections were
embedded in Vectashield mounting medium (Vector Laboratories,
UK). All speciemens were examined using a confocal microscope
Olympus FV 1000 SIM.
ZO-1 expression was measured by incubating the sections with
rabbit polyclonal anti-ZO-1 or anti-claudin-1 antibodies (Zymed
Laboratories Inc., San Francisco, CA) at 4uC overnight, washing
them, and incubating them with goat anti-rabbit IgG-FITC (in
10% PBS- normal goat serum, Zymed Laboratories Inc.) for 2 h.
Control sections were treated similarly, except that they were
incubated with secondary antibodies only. Images of the
specimens were viewed under an Olympus BX 40 microscope
that was equipped with an Olympus DP 70 digital camera.
Western blot of tissue lysates
Intestinal tissue from the loops was homogenized on ice in
protein extract buffer (Pierce, Rockford, IL) with a protease
inhibitor cocktail (Pierce) for 10 min and sonicated. Samples were
centrifuged at 10,0006 rpm for 10 min at 4uC and stored at
280uC until use. Protein concentrations were measured using the
BCA Protein Assay Kit (Pierce).
Proteins were denatured with sample buffer (106 mmol/L Tris-
HCl, 141 mmol/L Tris base pH 8.5, 0.51 mmol/L EDTA, 10%
glycerol, 2% SDS, 0.22 mmol/L SERVA blue G250, 0.175 mmol/
L phenol red, 0.1 mmol/L 2-mercaptoethanol) for 5 min at 100uC,
separated on a 10% (for claudin-1) or gradient 5% to 20% (for
ZO-1) polyacrylamide gel and blotted onto 0.2-mm PVDF
membranes (Serva, Germany).
The membranes were blocked with 2% (w/v) dry milk in 0.05%
PBS-Tween-20 for 1 h at room temperature and incubated
overnight at 4uC with antibodies against claudin-1 (1:1000), ZO-
1 (1:1000) (ZYMED Laboratories Inc.), and b-actin (1:5000)
(Abcam, Cambridge, MA, USA). After incubation with the
respective primary antibodies, the membranes were washed 3
times for 5 min in 0.05% PBS-Tween-20 and exposed to species-
specific horseradish peroxidase-labeled secondary antibodies
(1:1000) (ZYMED Laboratories) for 1 h at room temperature.
The reactions were developed using the ECL Plus Western
blotting reagent (Pierce), and the signal intensities were measured
on the LAS-1000 luminescence detector (Fujifilm, Tokyo, Japan)
and processed with AIDA 1000/1D Image Analyzer software,
version 3,28 (Raytest Isotopenmmessgeraete GmbH, Strauben-
hardt, Germany). After stripping, all membranes were re-probed
with antibodies against b-actin (1: 5000, Abcam), to document the
same protein concentration in all samples.
Scanning electron microscopy
Terminal ileum tissue was fixed in 3% glutaraldehyde in 0.1 M
cacodylate buffer (pH 7.2), dehydrated in an ethanol series (50, 70,
80, 90, 96, 100, and 100% v/v), transferred to 100% (v/v)
acetone, and dried in a BALZERS CPD 010 critical-point dryer
(Balzers, Lichtenstein). The samples were then sputter-coated with
gold and examined on an Aquasem electron microscope (Tescan,
Czech Republic) in the SEM mode.
Rat cytokine array
The cytokine spectra in the rat intestinal loop washes were
measured using the semiquantitative RayBio
TM Rat Cytokine
Antibody Array 1 (RayBiotech, Norcross, GA, USA), which detects
19 growth factors, cytokines, and chemokines, following the
manufacturer’s recommendations. The signal intensity was mea-
sured on an LAS-1000 luminescence detector (Fujifilm), and the
resulting images were analyzed using AIDA software (version 3.28;
Raytest) to quantify spot densities. The background staining was
subtracted, and the data were normalized as described [33].
Statistical analysis
Statistical analysis was performed using SPSS, version 17.0
(SPSS Inc., Chicago, IL, USA). To establish the homogeneity of
variances and the distribution of the data, the Levene test was run.
As a result of the non-normal distribution of the data and the
nonhomogeneity of the variances, Mann-Whitney U-test was used
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medians and quartiles. Different letters (a–e) mean statistically
significant differences between stimuli, the identical letters
correspond to non-significant differences. P,0.05 was considered
statistically significant.
Results
1. Goblet cell population in the jejunum is influenced by
gliadin and intestinal bacteria
The effect of gliadin and the proinflammatory cytokine IFN-c
on epithelial cells in the presence or absence of various bacterial
strains was examined in vivo using loops of small intestine that were
ligated surgically from rats kept on a gluten-free diet and reared
under germ-free (GF) conditions. As shown in Figure 1, the various
stimuli led to changes in the number of PAS-positive goblet cells
(examples A–F). To evaluate these changes, the number of PAS-
positive goblet cells per 100 epithelial cells was counted (as
summarized in Figure 1G). The addition of gliadin into the loops
decreased the number of PAS-positive goblet cells compared with
PBS used as a control. A similar effect was observed after applying
IFN-c alone and with gliadin (Figure 1B,G). The number of goblet
cells after combination of gliadin with E. coli CBL2 (Figure 1E,G)
or Shigella CBD8 (Figure 1C,G) was even lower. The addition of
IFN-c to above mentioned samples slightly increased the number
of goblet cells (Figure 1D,F,G).
When gliadin was combined with B. bifidum IATA-ES2
(Figure 1A), the number of PAS-positive goblet cells increased,
attaining the same value as in PBS-treated loops (Figure 1G).
Moreover, the combination of B. bifidum IATA-ES2 with
Shigella C B D 8 ,g l i a d i n ,a n dI F N - c increased the PAS-positive
goblet cell population. The effect of B. bifidum IATA-ES2 was
less evident when loops were exposed to E. coli CBL2
(Figure 1G).
Figure 1. Effects of bacterial strains and gliadin on goblet cells. Histological staining of PAS-positive goblet cells in rat intestinal loops
exposed to: B. bifidum IATA-ES2+gliadin (200 mg) (A), IFN-c (225 U) (B), Shigella CBD8+gliadin (C), Shigella CBD8+gliadin +IFN-c (D), E. coli CBL2+gliadin
(E) and E. coli CBL2+gliadin+IFN-c (F). Bacteria were applied at 10
6/loop. Changes in goblet cells are expressed as medians and interquartile ranges
(25% to 75%) of the number of PAS-positive goblet cells/100 epithelial cells (G). These values were for B. bifidum IATA-ES2 (39, 35–41), E. coli CBL2 (38,
35–41) and Shigella CBD8 (25, 20–27) when applied alone to the loops. Different letters (a–e) indicate statistically significant differences between
medians as calculated by Mann-Whitney U test (P,0.05). Identical letters correspond to non-significant differences. The separate dots or asterisks
indicate outliers. The pictures were obtained for the specimens viewed under an Olympus BX 40. Scale bar, 50 mm.
doi:10.1371/journal.pone.0016169.g001
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IATA-ES2 did not affect mucin secretion and did not evoke any
changes in intestinal loop architecture (Figure 2A). Mucin
secretion was slightly higher after the addition of gliadin (data
not shown). IFN-c, however, induced mucin release (Figure 2B),
and higher effect was observed when gliadin and E. coli CBL2 were
injected with IFN-c (Figure 2D). The combination of Shigella
CBD8, gliadin, and IFN-c boosted mucin secretion into the lumen
and impacted the architecture of the epithelial layer, as shown in
Figure 2F. Interestingly, addition of B. bifidum IATA-ES2 to
’’harmful agents’’ (gliadin and IFN-c with/without E. coli) slightly
decreased the mucin secretion as compared to those agents alone
(Figure 2C,E).
2. Translocation of gliadin into intestinal villi is influenced
by intestinal bacteria
We determined whether intestinal epithelial layer permeability
and gliadin peptide translocation was affected by bacterial strains.
Using mouse anti-gliadin antibody, we monitored the transfer of
gliadin peptides through the epithelial layer after exposure of the
intestinal loops to IFN-c and bacterial strains.
Gliadin, when applied with B. bifidum IATA-ES2 and IFN-c,
was observed only in low amounts inside the lamina propria -
forming foci mainly on the apical section of certain villi (Figure 3A).
In contrast, the combination of E. coli CBL2, gliadin and IFN-c
induced small, local changes (crypt widening), and gliadin was
detected primarily below the epithelial layer (Figure 3B). The
combination of Shigella CBD8, gliadin, and IFN-c increased
gliadin translocation, and gliadin was detected primarily inside the
lamina propria (Figure 3C). Furthermore, using differential
interference contrast (Figure 3D–F corresponding to samples in
upper row), we confirmed the decrease in a number of goblet cells
in loops treated with E. coli CBL2 and their loss after treatment
with Shigella CBD8, documented in Figure 1.
These data are also consistent with our fluorescence microscopy
results, which demonstrated the distribution of TJ components,
claudin-1, and ZO-1 in intestinal loops that were treated with
gliadin, IFN-c, and/or various bacterial strains (Figure 4A–J).
Gliadin alone or with IFN-c downregulated ZO-1 expression
(Figure 4A,C) compared to PBS-exposed loops (Figure 4I). On the
other hand, simultaneous addition of B. bifidum IATA-ES2 with
IFN-c and gliadin upregulated ZO-1 expression (Figure 4E).
When the loops were simultaneously exposed to E. coli CBL2,
gliadin and IFN-c, ZO-1 fluorescence was reduced (Figure 4G).
In contrast, the typical pattern of claudin-1 expression at the
periphery of intercellular (enterocyte) contacts was unaffected by
addition of gliadin alone or with IFN-c, B. bifidum IATA-ES2 or E.
coli CBL2 (Figure 4B,D,F,H) compared to PBS-treated loops
(Figure 4J). Nevertheless, the combination of gliadin, IFN-c, and
Shigella CBD8 nearly extinguished ZO-1 and claudin-1 signals
(data not shown).
To support the fluorescence microscopy findings, intestinal
tissue from the stimulated loops was extracted, and changes in TJ
proteins were measured by western blot. As shown in Figure 4K,
ZO-1 expression was more sensitive to various stimuli than
claudin-1. Gliadin, IFN-c, and, particularly, their combination
with E. coli CBL2 reduced ZO-1 levels in tissues. The addition of
B. bifidum IATA-ES2 to this mixture increased ZO-1 levels,
confirming the fluorescence microscopy data. When B. bifidum
IATA-ES2 was added with gliadin, ZO-1 levels approximated to
those of the PBS control. When Shigella CBD8 was used, the
fragmentation of TJ proteins was detected (data not shown).
3. Interaction of bacteria with the epithelial layer in vitro
The different effects of bacterial strains on gliadin translocation
and expression might be a consequence of differences in the
adhesion properties of individual bacterial strains that determine
host-microbe interactions.
Figure 2. Mucin production by goblet cells in rat intestinal loops. Mucin production after application of B. bifidum IATA-ES2 (A), IFN-c (B),
gliadin+IFN-c+ B. bifidum IATA-ES2 (C), E. coli CBL2+gliadin+IFN-c D), E. coli BL2+gliadin+ IFN-c+B. bifidum IATA-ES2 (E) and Shigella
CBD8+gliadin+IFN-c (F). Bacteria were applied at 10
6/loop. The samples were coated with gold and examined by Aquasem electron microscopy
(Tescan, Czech Republic) in the SEM mode. Scale bar, 20 mm.
doi:10.1371/journal.pone.0016169.g002
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or healthy subjects (which comprise potentially beneficial and
pathogenic bacteria) with epithelial cells was analyzed in vitro using
the IEC-6 rat cell line; the adherence of bacteria to IEC-6 cells and
the impact of gliadin were measured. As shown in Figure 5, the
percentage of adhered bacteria varied only slightly, and the
differences between E. coli CBL2, Shigella CBD8 and B. bifidum
IATA-ES2, were not statistically significant. The simultaneous
addition of gliadin fragments and bacteria to cell cultures had an
insignificant effect on bacterial adhesion.
4. Cytokine secretion into the gut lumen
Cytokine production in response to administration of food and
bacterial antigens and IFN-c to rat intestinal loops was measured
in intestinal washes by cytokine array (Figure 6A–H). The
secretion of cytokines, such as chemotactic factor for monocytes
and neutrophils (MCP)-1, tissue inhibitor of metalloproteinase
(TIMP)-1, vascular endothelial growth factor (VEGF), and beta-
nerve growth factor b-(NGF), increased.
The most abundant cytokines, MCP-1 and TIMP-1, which play
a role in tissue protection, were induced by B. bifidum IATA-ES2 in
a mixture of gliadin and IFN-c. The addition of E. coli CBL2 to
this mixture decreased MCP-1 and TIMP-1 release into the
intestinal loops. VEGF secretion rose, particularly by the addition
of E. coli CBL2 to gliadin and IFN-c but was unaffected by
simultaneous addition of B. bifidum IATA-ES2 to this mixture.
The spontaneous production of b-NGF was independent of any
stimulus. Further, cytokine-induced neutrophil chemoattractant
(CINC)-3, IFN-c, IL-10, IL-1a, IL-1b, IL-6, macrophage inflam-
matory protein (MIP)-3a,a n dT N F - a levels were low. Although it
was difficult to determine the effect of the stimuli on low cytokine
production, CINC-3 was detected only in loops that were inoculated
with E. coli CBL2. In PBS treated loops the cytokine IL-10, IL-1a,
IL-1b, and TNF-a were undetectable (as summarized in Figure 6H).
When Shigella CBD8 replaced E. coli CBL2, cytokine levels
increased markedly. Nevertheless, the high background of the
microarrays, reflecting the impact of Shigella CBD8 on intestinal
tissue, rendered the precise evaluation of these data impossible.
Discussion
There is limited data on the effects of bacteria and their
components on the intestinal barrier and the immune response to
dietary proteins. In this study, we observed the effects of
potentially pathogenic bacterial strains, isolated from the feces of
celiac patients or bifidobacteria, on gliadin- and IFN-c-induced
immune reactions.
Gliadin, when applied into the intestinal loops of germ-free rats
with the Gram-negative bacterial strain E. coli CBL2 and Shigella
CBD8, significantly reduced the number of PAS-positive goblet
cells in the jejunum; the opposite effect was observed when B.
bifidum IATA-ES2 was applied. The decreased caused by gliadin
alone was nearly completely reversed by the addition of B. bifidum
IATA-ES2. Moreover, the decline of PAS-positive goblet cell
population that was caused by gliadin and E. coli CBL2 or Shigella
CBD8 was lower when they were combined with B. bifidum IATA-
ES2 and/or IFN-c. The decrease in number of goblet cells
appeared to be caused by massive mucin secretion or cell
exhaustion, accompanied by changes in jejunal architecture,
similar to the changes that occur in the early stages of CD [34].
The direct effect of intestinal microbiota on the number of PAS-
positive goblet cells and on the composition and secretion of
mucins occurs on colonization of GF animals - namely, mice and
rats. In GF rodents, goblet cells were shown to be fewer in number
and smaller in size and mucus layer is thicker compared with
conventionally raised animals. In rats that are raised under GF
conditions and inoculated with human fecal microbes (human
microbiota-associated rats), the number of mucin-containing
Figure 3. Changes in intestinal permeability induced by gliadin and various bacterial strains. Intestinal loops were exposed to: gliadin
fragments with IFN-c and B. bifidum IATA-ES2 (A,D), gliadin+IFN-c+E. coli CBL2 (B,E) and Shigella CBD8+gliadin+IFN-c (C,F); The white arrows indicate
gliadin fragments found by immunofluorescence (A–C) using mouse peroxidase-labeled monoclonal anti-gliadin antibody and TSA
TM Plus
Fluorescence systems and black arrows indicate goblet cells (D, E). Bacteria were applied at 10
6/loop. The specimens were viewed under confocal
microscope Olympus FV 1000 SIM using differential interference contrast (D–F). Scale bar, 20 mm.
doi:10.1371/journal.pone.0016169.g003
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raised rats [35–37].
Commensal and pathogenic bacteria and bacterial LPS induce
host goblet cells to produce glycosylated mucins that are digestible
and beneficial for their own metabolism. An example is the
monoassociation of GF mice with wild-type Bacteroides thetaiotaomi-
cron (gut commensal), which induce the production of fructosylated
glycoconjugates, used by the bacterium as a nutrient source
[38–41].
Studies have shown that dietary factors affect goblet cell
numbers and modulate their secretory activity [37,42,43]. The
activating property of gliadin was also demonstrated in vivo in GF
rats; where repeated oral administration of gliadin to neonatal rats
led to effects like colonization with SPF (specific pathogen-free)
microbiota [32]. In earlier reports, increased glycoprotein
synthesis in jejunal tissue were observed in untreated celiac
patients [44,45].
Our finding of mucin secretion by goblet cells, as documented
by scanning electron microscopy, suggests that IFN-c induced
secretion is partially compensated by increased mucin synthesis.
The markedly increased mucin secretion that is induced by
enterobacteria with gliadin and IFN-c, however, is accompanied
Figure 4. Distribution of claudin-1 and ZO-1 in rat intestinal
loops. Exposure of intestinal tissue to gliadin digest alone (A) or with
IFN-c (C) led to reduced ZO-1 expression at the periphery of the villi.
The combination of gliadin+IFN-c+B. bifidum IATA-ES2 (E) maintained
the original level of ZO-1 as in PBS-treated loops (I). When gliadin+IFN-c
were applied with E. coli CBL2 (G) ZO-1 fluorescence was weaker. No
changes in claudin-1 localization (B, D, F, H) were detected after any
stimulus in comparison with PBS control (J). Representative pictures of
three experiments are shown. The specimens were viewed under an
Olympus BX 40 microscope. Scale bar, 20 mm. Western blot of tissue
lysates (K) from intestinal loops stimulated with: 1. gliadin, 2.
gliadin+IFN-c,3 .B. bifidum IATA-ES2+gliadin, 4. E. coli CBL2+gliadin
+IFN-c,5 .E. coli CBL2+B. bifidum IATA-ES2+gliadin+IFN-c,6 .B. bifidum
IATA-ES2+gliadin+IFN-c, and 7. PBS. The separated proteins on
Figure 5. Adhesion of different bacterial strains to IEC-6 cells.
The highest percentage of adhered bacteria was observed for E. coli
CBL2 and Shigella CBD8. The differences between tested bacterial
strains, as well as the effect of simultaneously added gliadin fragments
were non-significant as established by applying the Mann-Whitney U-
test. Data are expressed as medians and interquartile ranges (25% to
75%) of adhesion of four independent experiments. None of the
differences was found to be statistically significant (P,0.05). The
separate dot indicates an outlier.
doi:10.1371/journal.pone.0016169.g005
membranes were stained with anti ZO-1 or claudin-1 antibodies and
re-probed with antibodies against b-actin to document the same
protein concentration in all samples.
doi:10.1371/journal.pone.0016169.g004
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to tight junctions, and remodeling of the epithelial layer.
Recently, the effect of gliadin on the epithelial layer was noted
in in vitro studies using epithelial cell lines. Exposure to peptic-
tryptic fragments of gluten or gliadin leads to increased
permeability of Caco-2 monolayers, a human colon epithelial cell
line, due to lower expression of TJ proteins [21,22,46,47]. Our
experiments with rat intestinal loops confirmed the decreased
expression of the TJ protein ZO-1 after in vivo stimulation with
gliadin, IFN-c, and/or enterobacteria from CD patients by
immunofluorescence and western blot. The second protein band
reacting with anti ZO-1 antibodies in some samples, also shown by
others [48–50], could be a consequence of partial aggregation,
complex formation, or external stimuli. In addition, our results
demonstrate that these adverse effects are partially restored by B.
bifidum IATA-ES2.
We noted a spectrum of cytokines in the intestinal washes after
various stimuli. Secretion of TIMP-1 (inhibitor of metalloprotei-
nase, an enzyme of the endopeptidase family, important in
resorption and remodeling of extracellular matrix) was decreased
after gliadin treatment and increased after the addition of B.
bifidum IATA-ES2 and IFN-c. The effect of gliadin is consistent
with the upregulation of intestinal metalloproteinases and changes
in TIMPs in patients with celiac disease and dermatitis
herpetiformis [51–53].
In a recent study, we observed that the two enterobacteria
studied E. coli CBL2 and Shigella CBD8, induced proinflammatory
signals in PBMCs (peripheral blood mononuclear cells) through an
intact epithelial barrier (Caco-2 cells). This property appeared to
be associated with the pathogenic potential of the strains.
Stimulation of Caco-2 cells with other Bifidobacterium strains did
not exert similar effects, confirming that the intestinal epithelial
cells provided a physical barrier, preventing overstimulation and
inhibiting monocyte activation [54].
It has been suggested that the beneficial effects of bifidobacteria
are related to their ability to adhere to the epithelial layer,
preventing the adhesion of pathogenic bacteria. Yet, the
potentially pathogenic strains that we tested have similar adhesion
properties as B. bifidum IATA-ES2. The adhesion of pathogens to
host tissues might be a potentially negative hallmark, especially
adhesion to the damaged tissue, which is often the first step in
pathogenesis [55,56].
In conclusion, our data in GF rat intestinal loops highlight the
potential for gliadin fragments and/or IFN-c to reduce the
number of PAS-positive goblet cells and increase mucin secretion;
changes typical for early stages of enteropathies in general.
Interestingly, the changes induced by gluten and IFN-c were more
pronounced when these agents were combined with potentially
pathogenic enterobacteria. The decrease in PAS-positive goblet
cells by gliadin was reversed in the presence of B. bifidum IATA-
ES2. Moreover, enterobacteria can contribute to the translocation
of gliadin fragments into intestinal loops and to changes in ZO-1
expression. Interestingly, B. bifidum IATA-ES2 has beneficial
effects on cytokine secretion into intestinal loops, upregulating
chemotactic factors and inhibitors of metalloproteinases and thus
contributing to gut mucosal protection. Therefore, we hypothesize
Figure 6. Cytokine array analysis of rat intestinal loops washes. Layout of the arrays (A), cytokine profiles from loops treated with PBS
(control) (B), gliadin (C), gliadin+IFN-c (D), B. bifidum IATA-ES2+gliadin+IFN-c (E), E. coli CBL2+gliadin+IFN-c (F), and E. coli CBL2+B. bifidum IATA-
ES2+gliadin+IFN-c (G). The data are expressed as relative levels of selected cytokines (percentage of positive controls). Cytokine-induced neutrophil
chemoattractant (CINC)-2 and -3, monocyte chemoattractant protein (MCP)-1, macrophage inflammatory protein (MIP)-3a, nerve growth factor b-
(NGF), tumor necrosis factor (TNF)-a, vascular endothelial growth factor (VEGF). The signal intensity was measured using the LAS-1000 luminescence
detector (Fujifilm, Tokyo, Japan).
doi:10.1371/journal.pone.0016169.g006
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or absence of specific bacteria could play a role in CD
pathogenesis.
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